Literature DB >> 15564013

The role of bronchoalveolar lavage in interstitial lung disease.

Keith C Meyer1.   

Abstract

Considerable progress has been made in understanding the similarities and differences among the forms of the interstitial lung diseases (ILDs), particularly the forms of idiopathic interstitial pneumonia, now recognized as distinct clinicopathologic entities. Lung parenchymal evaluation by high-resolution CT scanning of the chest may provide images that are virtually diagnostic of certain forms of ILD, but other testing, including bronchoalveolar lavage (BAL) and lung biopsy, may be required for accurate diagnosis. The differential diagnosis of these disorders rests on the clinician's interpretation of the clinical presentation and physical examination findings, pulmonary function testing, radiographic imaging, and, if required, sampling of lung tissue. This discussion examines the usefulness of BAL in the diagnosis of specific forms of ILD.

Entities:  

Mesh:

Year:  2004        PMID: 15564013     DOI: 10.1016/j.ccm.2004.08.001

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  10 in total

1.  Bronchoalveolar lavage cell pattern from healthy human lung.

Authors:  M Heron; J C Grutters; K M ten Dam-Molenkamp; D Hijdra; A van Heugten-Roeling; A M E Claessen; H J T Ruven; J M M van den Bosch; H van Velzen-Blad
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

2.  Connective tissue disease associated interstitial pneumonia: a challenge for both rheumatologists and pulmonologists.

Authors:  Sarah Geerts; Wim Wuyts; Ellen De Langhe; Jan Lenaerts; Jonas Yserbyt
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

Review 3.  Shotgun MS proteomic analysis of bronchoalveolar lavage fluid in normal subjects.

Authors:  Elizabeth V Nguyen; Sina A Gharib; Lynn M Schnapp; David R Goodlett
Journal:  Proteomics Clin Appl       Date:  2014-10       Impact factor: 3.494

Review 4.  Interstitial lung disease: the diagnostic role of bronchoscopy.

Authors:  Jad Kebbe; Tony Abdo
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

5.  Effects of cage-change frequency and bedding volume on mice and their microenvironment.

Authors:  Matthew D Rosenbaum; Susan VandeWoude; Thomas E Johnson
Journal:  J Am Assoc Lab Anim Sci       Date:  2009-11       Impact factor: 1.232

Review 6.  Noninfectious interstitial lung disease during infliximab therapy: case report and literature review.

Authors:  Roberta Caccaro; Edoardo Savarino; Renata D'Incà; Giacomo Carlo Sturniolo
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

7.  BAL biomarkers' panel for differential diagnosis of interstitial lung diseases.

Authors:  Miriana d'Alessandro; Alfonso Carleo; Paolo Cameli; Laura Bergantini; Anna Perrone; Lucia Vietri; Nicola Lanzarone; Cecilia Vagaggini; Piersante Sestini; Elena Bargagli
Journal:  Clin Exp Med       Date:  2020-01-22       Impact factor: 3.984

8.  Drug induced interstitial lung disease.

Authors:  Martin Schwaiblmair; Werner Behr; Thomas Haeckel; Bruno Märkl; Wolfgang Foerg; Thomas Berghaus
Journal:  Open Respir Med J       Date:  2012-07-27

9.  PSMB2 and RPL32 are suitable denominators to normalize gene expression profiles in bronchoalveolar cells.

Authors:  Eva Kriegova; Arsen Arakelyan; Regina Fillerova; Jaromir Zatloukal; Frantisek Mrazek; Zdenka Navratilova; Vitezslav Kolek; Roland M du Bois; Martin Petrek
Journal:  BMC Mol Biol       Date:  2008-07-31       Impact factor: 2.946

Review 10.  Prognosis and treatment of FOLFOX therapy related interstitial pneumonia: a plea for multimodal immune modulating therapy in the respiratory insufficient patient.

Authors:  Annick De Weerdt; Amélie Dendooven; Annemie Snoeckx; Jan Pen; Martin Lammens; Philippe G Jorens
Journal:  BMC Cancer       Date:  2017-08-29       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.